Breaking Down SG&A Expenses: Johnson & Johnson vs MannKind Corporation

A Tale of Two Companies: SG&A Expenses Over Time

In the world of corporate finance, Selling, General, and Administrative (SG&A) expenses are a crucial indicator of a company's operational efficiency. This analysis compares the SG&A expenses of two contrasting companies: Johnson & Johnson and MannKind Corporation, from 2014 to 2023.

Johnson & Johnson, a healthcare giant, consistently reported SG&A expenses in the range of $19 billion to $22 billion annually. Despite a slight dip in 2022, their expenses remained relatively stable, reflecting their robust market position and operational scale.

Conversely, MannKind Corporation, a smaller biopharmaceutical company, exhibited more volatility. Their SG&A expenses fluctuated between $47 million and $108 million, with a notable peak in 2015. This variability highlights the challenges faced by smaller firms in managing operational costs.

Overall, Johnson & Johnson's SG&A expenses are approximately 250 times greater than MannKind's, underscoring the vast differences in scale and market presence between these two companies.